Strongbridge Biopharma PLC (SBBP) Stock Price Target Moved to $18.00 at HC Wainwright

Strongbridge Biopharma PLC (NASDAQ: SBBP) shares rose on Wednesday January 25 on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock, increasing the price target of stock.

Meanwhile, the Dow Jones Industrial Average on Wednesday crossed the 20,000 level for the first time, while the S&P 500 and Nasdaq Composite also traded in record territory shortly after the market opened

The Dow Jones Industrial Average DJIA, +0.60% advanced 100 points, or 0.5%, to 20,012,
The S&P 500 index SPX, +0.55% gained 10 points, or 0.5%, to 2,289, with eight of the main 11 sectors trading higher.

The Nasdaq Composite index COMP, +0.66% was 30 points, or 0.6%, higher at 5,630.

All three main indexes set intraday records shortly after the opening bell.

Strongbridge Biopharma PLC (NASDAQ: SBBP) had its price target boosted by equities researchers at HC Wainwright from $15.00 to $18.00. HC Wainwright currently has a rating of Buy on the stock. A number of other analysts have issued reports on the stock recently, and the company has earned a consensus one-year price target of $13.33, higher than the opening price of $2.35. Strongbridge Biopharma PLC stock has a 52-week high of $6.39.

Shares of Strongbridge Biopharma PLC (NASDAQ: SBBP) opened at $2.35 yesterday and traded in a range between, $2.35 and $2.45, and last traded at $2.40, which is a jump of $0.05 over the previous closing price.

Strongbridge Biopharma PLC (NASDAQ: SBBP) currently has a market cap of 50.89M.

Strongbridge Biopharma PLC (NASDAQ: SBBP) Average Daily Trading Volume

25,914 shares crossed the trading desk yesterday, 84 percent below the average, out of a total float 8,934,000. lower than normal. Look for trading volume to pick up in the coming days as momentum traders often use swings in trading volume to identify heavy volume accumulation or distribution by institutional investors.

While increased trading for short periods will not mean much will not mean much, conversely, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These instituitional investors retain substantial teams of analysts that investigate thousands of stocks, so it is good confirmation to see them taking a postion in a stock you’re considering.

Strongbridge Biopharma PLC (NASDAQ: SBBP) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By spotting trends, moving averages allow traders to make those trends work in their favor and increase the number of winning trades.

With that in mind, Strongbridge Biopharma PLC (NASDAQ: SBBP) now has a 50-day MA of $2.88 and 200-day MA of $4.12. It has traded in a 52-week range between $2.00 – 6.39 and today’s last price is 62.44%% lower than the 52 week high of $6.39.

Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors look for companies that have increased their earnings by at least 25% for a 3 year period.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply